Managing Tardive Dyskinesia
Kevin N. Williams, MS, MPAS, PA-C
This video series by PA Kevin N. Williams explores Tardive Dyskinesia (TD), a movement disorder affecting individuals on dopamine-receptor blocking agents, particularly antipsychotics. It highlights the importance of early detection and monitoring of risk factors, the recognition of subtle signs through assessments like the Abnormal Involuntary Movement Scale (AIMS), and the differentiation between TD and drug-induced parkinsonism.
PA Williams discusses treatment options, advocating for VMAT2 inhibitors and empowering PAs to play an active role in managing TD. He emphasizes the need for patient education and open communication about the impact of TD on quality of life, ultimately equipping healthcare providers with the tools to improve patient outcomes.
Video 1: Before the Movements Start: Spotting Risk Factors for Tardive Dyskinesia
This video introduces Tardive Dyskinesia (TD), a movement disorder affecting over 800,000 people in the U.S., highlighting its risk factors and the importance of early detection for healthcare providers. It emphasizes the role of physician associates in educating patients and monitoring those at risk.
Video 2: From Subtle Signs to Significant Impact: Identifying TD in Your Patients
In this video, PA Williams discusses effective strategies for screening and diagnosing Tardive Dyskinesia (TD), emphasizing the importance of recognizing subtle signs in at-risk patients. He outlines essential assessment tools like the Abnormal Involuntary Movement Scale (AIMS) and highlights the differences between TD and drug-induced parkinsonism.
Video 3: From Diagnosis to Management: How to Treat Tardive Dyskinesia
In this video, PA Williams explores the management of Tardive Dyskinesia (TD), discussing its pathophysiology and emphasizing the importance of appropriate treatment strategies. He advocates for the use of VMAT2 inhibitors while clarifying common misconceptions about antipsychotic medications in TD management.
Video 4: Empowering Through Education: Talking TD with Your Patients
In this video, PA Williams focuses on empowering patients through education about Tardive Dyskinesia (TD), emphasizing the importance of open communication during medical visits. He provides practical strategies for discussing movement variability and monitoring the impact of TD on patients’ quality of life.
Supported by
